SPRC (SciSparc) שווי פעילות לרווח לפני ריבית, מסים ופחת

This EV/EBITDA chart for SciSparc Ltd (SPRC), with a value of 0.00, is available below. SciSparc Ltd focuses on independent trials of psychoactive compounds, collaborating exclusively with scientists. The business relies on outsourced synthesis in Europe to avoid plant expenditures. SciSparc Ltd develops drugs to combat Alzheimer's and Tourette's using a method to enhance effects at low doses.

EV/EBITDA determines the total enterprise value, including debt, relative to its operating profit before taxes and amortization. By analyzing the historical EV/EBITDA levels of a company, an investor identifies the balance between the asset's market price and its ability to generate cash flow. For SciSparc Ltd (SPRC), such a valuation confirms the stability of its capitalization, which is supported by the exceptional retention of key scientific staff in the field of neuroscience.